FDA NOTIFIES PUBLIC OF NATIONWIDE RECALL OF ENCLOSED BED SYSTEMS FROM VAIL PRODUCTS INC. FOR ASPHYXIATION RISK

On Friday, the FDA issued a public notification that Vail Products, Inc., Toledo, Ohio, has initiated a nationwide recall of approximately 5,000 "enclosed" bed systems. The enclosed bed systems have been found to cause patient entrapments, resulting in severe neurological damage or death due to asphyxiation.

Under the terms of the recall, the company has sent new instruction manuals and warning labels to every customer informing them of FDA’s advice to stop using the bed system, move patients to alternative beds systems if possible and consult with their physician.

If, no other bed systems are available, users are advised to follow the safety precautions contained in the new instruction manuals and warning labels to help minimize risk of injury (also available on FDA’s website, see below.)
The FDA notification states: “Vail enclosed bed systems are canopy-like padded beds covered with nylon netting that is zipped into place to enclose the patient. They are used for at-risk patients with cognitive impairment, unpredictable behavior, spasms, seizures, and other disorders. The beds are an alternative to physical or drug restraint to reduce falls or other injury to patients.

The bed systems pose a hazard in that patients can become entrapped between the side-rail and the mattress or between the canopy and mattress. Due to the presence of the canopy, if their head is entrapped, the patient may experience asphyxiation, which can result in permanent neurological injury or death. FDA is aware of approximately 30 entrapments, of which at least 8 resulted in death.”
 
"FDA is making every effort to make sure that patients and healthcare providers are aware of this problem and are given the information needed to help minimize risk," said Dr. Daniel Schultz, Director of FDA’s Center for Devices and Radiological Health.
 
The FDA first issued a Public Health Notification on March 25, 2005 about the potential risk posed by these bed systems. Yesterday it further updated its Public Health Notification (available at http://www.fda.gov/cdrh/safety/032505-vail.html) to reflect the latest information on this problem.

On June 23 and 24, 2005, Vail Products mailed corrected instruction manuals and labeling, including warning labels to all users of its Vail 500, Vail 1000, and Vail 2000 enclosed bed systems.

Vail Products announced on June 16, 2005, that it is permanently ceasing the manufacture, sale, and distribution of all Vail enclosed bed systems. Vail will no longer be available to provide accessories, replacement parts, or retrofit kits.

Users who have not received a copy of the corrected instruction manual may attempt to contact Vail Products at 1-800-235-8245.

The FDA encourages individual users to report any adverse events related to Vail enclosed bed systems to MedWatch, the FDA’s voluntary reporting program at 1-800-FDA-1088; by FAX at 1-800-FDA-0178; by mail to MedWatch, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857-9787; or online at http://www.fda.gov/medwatch/report.htm. Consumers can also report directly to MedWatch.

This entry was posted in Defective Products. Bookmark the permalink.


FDA NOTIFIES PUBLIC OF NATIONWIDE RECALL OF ENCLOSED BED SYSTEMS FROM VAIL PRODUCTS INC. FOR ASPHYXIATION RISK

On Friday, the FDA issued a public notification that Vail Products, Inc., Toledo, Ohio, has initiated a nationwide recall of approximately 5,000 "enclosed" bed systems. The enclosed bed systems have been found to cause patient entrapments, resulting in severe neurological damage or death due to asphyxiation.

Under the terms of the recall, the company has sent new instruction manuals and warning labels to every customer informing them of FDA’s advice to stop using the bed system, move patients to alternative beds systems if possible and consult with their physician.

If, no other bed systems are available, users are advised to follow the safety precautions contained in the new instruction manuals and warning labels to help minimize risk of injury (also available on FDA’s website, see below.)
The FDA notification states: “Vail enclosed bed systems are canopy-like padded beds covered with nylon netting that is zipped into place to enclose the patient. They are used for at-risk patients with cognitive impairment, unpredictable behavior, spasms, seizures, and other disorders. The beds are an alternative to physical or drug restraint to reduce falls or other injury to patients.

The bed systems pose a hazard in that patients can become entrapped between the side-rail and the mattress or between the canopy and mattress. Due to the presence of the canopy, if their head is entrapped, the patient may experience asphyxiation, which can result in permanent neurological injury or death. FDA is aware of approximately 30 entrapments, of which at least 8 resulted in death.”
 
"FDA is making every effort to make sure that patients and healthcare providers are aware of this problem and are given the information needed to help minimize risk," said Dr. Daniel Schultz, Director of FDA’s Center for Devices and Radiological Health.
 
The FDA first issued a Public Health Notification on March 25, 2005 about the potential risk posed by these bed systems. Yesterday it further updated its Public Health Notification (available at http://www.fda.gov/cdrh/safety/032505-vail.html) to reflect the latest information on this problem.

On June 23 and 24, 2005, Vail Products mailed corrected instruction manuals and labeling, including warning labels to all users of its Vail 500, Vail 1000, and Vail 2000 enclosed bed systems.

Vail Products announced on June 16, 2005, that it is permanently ceasing the manufacture, sale, and distribution of all Vail enclosed bed systems. Vail will no longer be available to provide accessories, replacement parts, or retrofit kits.

Users who have not received a copy of the corrected instruction manual may attempt to contact Vail Products at 1-800-235-8245.

The FDA encourages individual users to report any adverse events related to Vail enclosed bed systems to MedWatch, the FDA’s voluntary reporting program at 1-800-FDA-1088; by FAX at 1-800-FDA-0178; by mail to MedWatch, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857-9787; or online at http://www.fda.gov/medwatch/report.htm. Consumers can also report directly to MedWatch.

This entry was posted in Defective Products. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.